Nirmatrelvir–ritonavir (Paxlovid) significantly reduced the likelihood of hospitalization or death from COVID-19 in people at risk of severe illness, according to new research in Canadian Medical Association Journal (CMAJ).
from Medical Xpress - latest medical and health news stories https://ift.tt/medh0u8
